Health TrialsbyHealthPanel

Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians

ConditionsOvarian CarcinomaPsychiatric Disorder
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorFred Hutchinson Cancer Center

About this trial

This clinical trial tests an adapted version of the Helping Ovarian Cancer Patients Cope (HOPE) intervention to address burnout among gynecologic oncology clinicians. Stress and burnout among gynecologic oncology clinicians can have far-reaching impacts not only on physicians at the individual level (e.g., distress, mental illness) but also at the professional (e.g., worse patient outcomes, increased errors) and societal levels (fewer physicians in this specialty, more system strain). The original Helping Ovarian Cancer Patients Cope (HOPE) is a workshop to promote hope among patients with ovarian cancer through creating positive narratives using the hope theory and social-cognitive theory. The adapted intervention for clinicals (HOPE-C) will use the same concepts but tailored to clinician experiences by fostering peer support and retelling their challenging stories and may address burnout for gynecologic oncology clinicians.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age 18 years of age or older

English speaking

Able to provide informed consent

Working with patients with ovarian cancer (gynecologic oncologists, medical oncologists, nurses, social workers, and advance practice providers [APPs])

Disqualifiers

None

Trial design

Design model

Single group

Treatments tested in this trial

  • Behavioral Intervention

    Behavioral

    Complete HOPE-C sessions

  • Interview

    Other intervention

    Complete interview

  • Survey Administration

    Other intervention

    Ancillary studies

Treatment groups

25 Participants
are divided into 1 treatment group
Group A: HOPE-C interventionExperimental treatment 3 interventions

Trial outcomes

Primary outcomes

1

Objective 1: Clinician feedback for Helping Ovarian Cancer Patients Cope-Clinician Burnout (HOPE-C)

Will assess clinician's feedback around the content, delivery structure, and materials for the adapted HOPE-C intervention. Qualitative Description will be used to analyze the data.

Time frame
Day 1
2

Objective 2: Feasibility (Accrual rate)

Feasibility cutoff includes ≥ 50% of eligible clinicians enrolling in the study.

Time frame
At time of enrollment
3

Objective 2: Feasibility (Rate of intervention completion)

Feasibility cutoff includes ≥ 50% of enrolled clinicians completing all sessions.

Time frame
At 4 weeks
4

Objective 2: Feasibility (Rate of survey completion)

Feasibility cutoff includes ≥ 50% of enrolled clinicians completing all surveys.

Time frame
At baseline and 2-week post-intervention

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Fred Hutchinson Cancer Center

Lead sponsor

Andy Hill CARE Fund

Collaborator

Source ClinicalTrials.gov
Apply now